The director of the Cancer Epigenetics and Biology Program at IDIBELL, Professor of Genetics at the University of Barcelona and ICREA Research Professor, Manel Esteller has been awarded with the Rey Jaime I Prize in basic research in its 25th edition. The Rey Jaime I Awards Foundation celebrates its 25th anniversary with the participation of […]
Manel Esteller, Rey Jaime I Prize in basic research Read More »
Next Tuesday June 4 at 7 pm on CosmoCaixa puts an end to the cycle of conferences “The music and its impact on the body and mind” with a panel discussion on the future of research in music. In the discussion will participate the cycle coordinator, the researcher of the IDIBELL and the University of
Music and brain at CosmoCaixa Read More »
By 1950, cardiovascular disease mortality was 450 per 100,000 inhabitants. The advent of new techniques, new drugs and the identification of risk factors have made this figure has been reduced by 300%. The cardiologist at Hospital Clínico San Carlos, Madrid, Carlos Macaya has reviewed the milestones of interventional cardiology on May 24 at a conference
What stage of evolution, the human brain developed the language and the ability to make music? What made us different from other primates? These are some of the questions that drive research Josef Rauschecker Department of Neuroscience at Georgetown University, Washington. Rauschecker explained their progress on May 17 at a conference cycle framed within IDIBELL
Researchers of the IDIBELL have developed a preclinical therapeutic model to test new treatments for brain metastases in breast cancer patients. The results of the study are published in the International Journal of Molecular Sciences. Brain metastasis affects 30% of breast cancer patients who develop metastases. Currently the treatment of choice is radiotherapy. Only in
One, two, three… many. Studies with neuroimaging techniques confirm that the representation we make of numbers follows this pattern. Humans have specialized neurons that activates in front of one thing, two things, and three things. The rest are approximate representations. Josep Marco, researcher at the group of Brain Plasticity and Cognition at IDIBELL and the
Josep Marco: ”we have an approximate system to measure amounts” Read More »
In Europe there are about 2 million people with minimal Hepatic Encephalopathy, 200,000 in Spain. Most of them are undiagnosed so that cannot prevent the progression of the disease with cognitive and motor impairment that this entails. Vicente Felipo, researcher at the Centre Prince Felipe of Valencia explained on May 10 his progress in the
The IDIBELL researcher Gabriel Capellá has been appointed new Head of Research and Innovation for Health of the Health Department of the Generalitat de Catalunya, replacing Marta Aymerich. Capellá will combine this task with the responsabilities of head of the Hereditary Cancer Program of the ICO and leader of the IDIBELL Hereditary Cancer group. From
Researcher of the Center for Molecular Genetic Diagnosis at the IDIBELL and the Oncogenetics Laboratory and Unit High Risk and Prevention Cancer of the Hospital Vall d’Hebron have studied a family affected by both type 1 neurofibromatosis and early breast cancer and they have detected mutations in NF1 and BRCA1 genes responsible for the two
On April 2nd Marga Frontera joined IDIBELL as scientific office manager. Her mission, in her own words, is “getting the researcher, as far as possible, do not worry about anything but to investigate”. Frontera knows the day-to-day work in the laboratory because she has worked as a postdoctoral researcher in the laboratory of genomic imprinting
Marga Frontera, new scientific office manager at IDIBELL Read More »
